LINC01410 accelerates the invasion of trophoblast cells by modulating METTL3/Fas.
FAS
LINC01410
METTL3
Preeclampsia
m6A
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
08 Aug 2024
08 Aug 2024
Historique:
received:
21
06
2024
accepted:
30
07
2024
medline:
8
8
2024
pubmed:
8
8
2024
entrez:
8
8
2024
Statut:
epublish
Résumé
Insufficient trophoblast invasion, culminating in suboptimal uterine spiral artery remodeling, is pinpointed as a pivotal contributor to preeclampsia (PE) development. LINC01410 has been documented to be increased in various neoplasms, and is significantly associated with the invasive capabilities of tumor cells. Nonetheless, its function and the mechanisms in the pathogenesis of PE require further investigation. LINC01410 and methyltransferase-like 3 (METTL3) were ectopically expressed in HTR-8/Svneo cells via lentiviral transduction. Subsequently, the cells' invasive capabilities and apoptosis rates were evaluated employing Transwell assays and flow cytometry, respectively. The interplay between LINC01410 and METTL3, alongside the m6A methylation of FAS, was probed through RNA immunoprecipitation (RIP). Additionally, the association between FAS and METTL3 was elucidated via Coimmunoprecipitation (Co-IP) assays. The protein level of NF-κB, BAX, and BCL-2 in LINC01410-overexpressing cells was detected by Western blot. Our findings revealed that LINC01410 elevation increased the invasive ability of HTR-8/Svneo cells, directly impacting METTL3 then leading to its reduced expression. Conversely, heightened METTL3 expression mitigated invasiveness while enhancing apoptosis in these cells. Moreover, METTL3's interaction with FAS led to increased FAS expression, subject to m6A methylation. A surge in LINC01410 markedly decreased both mRNA and protein levels of FAS. Furthermore, LINC01410 overexpression significantly reduced NF-κB and BAX protein levels while augmenting BCL-2. Upregulation of LINC01410 expression promotes trophoblast cell invasion by inhibiting FAS levels through modified m6A alteration and suppressing the NF-κB pathway. These findings underscore the pivotal role of LINC01410 in regulating trophoblast cell invasion and propose it as a promising therapeutic strategy for preventing or alleviating PE. This offers valuable insights for the clinical treatment of PE, for which definitive targeted therapy methods are currently lacking.
Sections du résumé
BACKGROUND
BACKGROUND
Insufficient trophoblast invasion, culminating in suboptimal uterine spiral artery remodeling, is pinpointed as a pivotal contributor to preeclampsia (PE) development. LINC01410 has been documented to be increased in various neoplasms, and is significantly associated with the invasive capabilities of tumor cells. Nonetheless, its function and the mechanisms in the pathogenesis of PE require further investigation.
METHODS AND RESULTS
RESULTS
LINC01410 and methyltransferase-like 3 (METTL3) were ectopically expressed in HTR-8/Svneo cells via lentiviral transduction. Subsequently, the cells' invasive capabilities and apoptosis rates were evaluated employing Transwell assays and flow cytometry, respectively. The interplay between LINC01410 and METTL3, alongside the m6A methylation of FAS, was probed through RNA immunoprecipitation (RIP). Additionally, the association between FAS and METTL3 was elucidated via Coimmunoprecipitation (Co-IP) assays. The protein level of NF-κB, BAX, and BCL-2 in LINC01410-overexpressing cells was detected by Western blot. Our findings revealed that LINC01410 elevation increased the invasive ability of HTR-8/Svneo cells, directly impacting METTL3 then leading to its reduced expression. Conversely, heightened METTL3 expression mitigated invasiveness while enhancing apoptosis in these cells. Moreover, METTL3's interaction with FAS led to increased FAS expression, subject to m6A methylation. A surge in LINC01410 markedly decreased both mRNA and protein levels of FAS. Furthermore, LINC01410 overexpression significantly reduced NF-κB and BAX protein levels while augmenting BCL-2.
CONCLUSIONS
CONCLUSIONS
Upregulation of LINC01410 expression promotes trophoblast cell invasion by inhibiting FAS levels through modified m6A alteration and suppressing the NF-κB pathway. These findings underscore the pivotal role of LINC01410 in regulating trophoblast cell invasion and propose it as a promising therapeutic strategy for preventing or alleviating PE. This offers valuable insights for the clinical treatment of PE, for which definitive targeted therapy methods are currently lacking.
Identifiants
pubmed: 39115693
doi: 10.1007/s11033-024-09834-6
pii: 10.1007/s11033-024-09834-6
doi:
Substances chimiques
Methyltransferases
EC 2.1.1.-
METTL3 protein, human
EC 2.1.1.62
fas Receptor
0
FAS protein, human
0
RNA, Long Noncoding
0
NF-kappa B
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
895Subventions
Organisme : General Project of the Natural Science Foundation of Hainan Province
ID : 821MS123
Organisme : General Project of the Natural Science Foundation of Hainan Province
ID : 821MS124
Informations de copyright
© 2024. The Author(s).
Références
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D’Alton M, Berghella V, Nicolaides KH, Hod M (2019) The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet 145(Suppl 1):1–33. https://doi.org/10.1002/ijgo.12802
doi: 10.1002/ijgo.12802
pubmed: 31111484
pmcid: 6944283
Liu YH, Zhang YS, Chen JY, Wang ZJ, Liu YX, Li JQ, Xu XJ, Xie NJ, Lye S, Tan N, Duan CY, Wei YX, He PC (2023) Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials. Am J Obstet Gynecol 228:535–546. https://doi.org/10.1016/j.ajog.2022.10.014
doi: 10.1016/j.ajog.2022.10.014
pubmed: 36283479
Miller EC, Wilczek A, Bello NA, Tom S, Wapner R, Suh Y (2022) Pregnancy, preeclampsia and maternal aging: from epidemiology to functional genomics. Ageing Res Rev 73:101535. https://doi.org/10.1016/j.arr.2021.101535
doi: 10.1016/j.arr.2021.101535
pubmed: 34871806
Arutyunyan A, Roberts K, Troule K, Wong FCK, Sheridan MA, Kats I, Garcia-Alonso L, Velten B, Hoo R, Ruiz-Morales ER, Sancho-Serra C, Shilts J, Handfield LF, Marconato L, Tuck E, Gardner L, Mazzeo CI, Li Q, Kelava I, Wright GJ, Prigmore E, Teichmann SA, Bayraktar OA, Moffett A, Stegle O, Turco MY, Vento-Tormo R (2023) Spatial multiomics map of trophoblast development in early pregnancy. Nature 616:143–151. https://doi.org/10.1038/s41586-023-05869-0
doi: 10.1038/s41586-023-05869-0
pubmed: 36991123
pmcid: 10076224
Rayburn WF (2020) The placenta: its importance from womb to Tomb. Obstet Gynecol Clin North Am 47:xiii–xiv. https://doi.org/10.1016/j.ogc.2020.01.002
Jie Q, Chen L, Liang J, Yang X, Sun F, Ma Y (2023) Downregulated ETV4 inhibits the proliferation, migration, and invasion of trophoblast cells in preeclampsia. Reproduction 165:373–381. https://doi.org/10.1530/REP-22-0184
doi: 10.1530/REP-22-0184
pubmed: 36716247
Wang H, Feng Y, Zheng X, Xu X (2023) The diagnostic and therapeutic role of snoRNA and lincRNA in bladder Cancer. Cancers (Basel) 15. https://doi.org/10.3390/cancers15041007
Lekva T, Sundaram AYF, Roland MCP, Asheim J, Michelsen AE, Norwitz ER, Aukrust P, Gilfillan GD, Ueland T (2023) Platelet and mitochondrial RNA is decreased in plasma-derived extracellular vesicles in women with preeclampsia-an exploratory study. BMC Med 21:458. https://doi.org/10.1186/s12916-023-03178-x
doi: 10.1186/s12916-023-03178-x
pubmed: 37996819
pmcid: 10666366
Jiang S, Chen Q, Liu H, Gao Y, Yang X, Ren Z, Gao Y, Xiao L, Zhong M, Yu Y, Yang X (2020) Preeclampsia-Associated lncRNA INHBA-AS1 regulates the Proliferation, Invasion, and Migration of placental trophoblast cells. Mol Ther Nucleic Acids 22:684–695. https://doi.org/10.1016/j.omtn.2020.09.033
doi: 10.1016/j.omtn.2020.09.033
pubmed: 33230466
pmcid: 7585871
Chen Q, Jiang S, Liu H, Gao Y, Yang X, Ren Z, Gao Y, Xiao L, Hu H, Yu Y, Yang X, Zhong M (2020) Association of lncRNA SH3PXD2A-AS1 with preeclampsia and its function in invasion and migration of placental trophoblast cells. Cell Death Dis 11:583. https://doi.org/10.1038/s41419-020-02796-0
doi: 10.1038/s41419-020-02796-0
pubmed: 32719429
pmcid: 7385659
Sendinc E, Shi Y (2023) RNA m6A methylation across the transcriptome. Mol Cell 83:428–441. https://doi.org/10.1016/j.molcel.2023.01.006
doi: 10.1016/j.molcel.2023.01.006
pubmed: 36736310
Gu J, Cao H, Chen X, Zhang XD, Thorne RF, Liu X (2024) RNA m6A modifications regulate crosstalk between tumor metabolism and immunity. Wiley Interdiscip Rev RNA 15:e1829. https://doi.org/10.1002/wrna.1829
doi: 10.1002/wrna.1829
pubmed: 38114887
Fang Z, Mei W, Qu C, Lu J, Shang L, Cao F, Li F (2022) Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol 11:45. https://doi.org/10.1186/s40164-022-00298-7
doi: 10.1186/s40164-022-00298-7
pubmed: 35945641
pmcid: 9361621
Jin Y, Fan Z (2024) New insights into the interaction between m6A modification and lncRNA in cancer drug resistance. Cell Prolif 57:e13578. https://doi.org/10.1111/cpr.13578
doi: 10.1111/cpr.13578
pubmed: 37961996
Chen S, Dong J, Luo X, Nie Z, Lu S, Liu H, Liu J (2022) Interaction between m6A and ncRNAs and its Association with diseases. Cytogenet Genome Res 162:171–187. https://doi.org/10.1159/000526035
doi: 10.1159/000526035
pubmed: 36122561
Xie J, Zhang H, Wang K, Ni J, Ma X, Khoury CJ, Prifti V, Hoard B, Cerenzia EG, Yin L, Zhang H, Wang R, Zhuo D, Mao W, Peng B (2023) M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription. Oncogene 42:2956–2970. https://doi.org/10.1038/s41388-023-02814-3
doi: 10.1038/s41388-023-02814-3
pubmed: 37612524
pmcid: 10541332
Du A, Li S, Zhou Y, Disoma C, Liao Y, Zhang Y, Chen Z, Yang Q, Liu P, Liu S, Dong Z, Razzaq A, Tao S, Chen X, Liu Y, Xu L, Zhang Q, Li S, Peng J, Xia Z (2022) M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer 21:109. https://doi.org/10.1186/s12943-022-01575-z
doi: 10.1186/s12943-022-01575-z
pubmed: 35524319
pmcid: 9074191
Saleh AA, Elghobashy YA, Kasemy ZA, Hegazy A, AA AL (2024) Impact of Dysregulated LINC01559 and LINC01410 expression on the diagnosis and survival of Non-small Cell Lung Cancer. Biochem Genet. https://doi.org/10.1007/s10528-023-10632-1
doi: 10.1007/s10528-023-10632-1
pubmed: 39028381
Mou L, Wang L, Zhang S, Wang Q (2021) Long noncoding RNA LINC01410 suppresses tumorigenesis and enhances radiosensitivity in Neuroblastoma cells through regulating miR-545-3p/HK2 Axis. Onco Targets Ther 14:3225–3238. https://doi.org/10.2147/OTT.S297969
doi: 10.2147/OTT.S297969
pubmed: 34040388
pmcid: 8140916
Fu T, Yang Y, Mu Z, Sun R, Li X, Dong J (2021) Silencing lncRNA LINC01410 suppresses cell viability yet promotes apoptosis and sensitivity to temozolomide in glioblastoma cells by inactivating PTEN/AKT pathway via targeting miR-370-3p. Immunopharmacol Immunotoxicol 43:680–692. https://doi.org/10.1080/08923973.2021.1966031
doi: 10.1080/08923973.2021.1966031
pubmed: 34435542
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
doi: 10.1006/meth.2001.1262
pubmed: 11846609
Yang Y, Lan RH, Gong HMJ海英 (2021) Clinical significance of lncRNA LINC01410 in preeclampsia and its effect on trophoblast proliferation and invasion. 27:5
Ayala-Ramirez P, Machuca-Acevedo C, Gamez T, Quijano S, Barreto A, Silva JL, Olaya CM, Garcia-Robles R (2021) Assessment of placental extracellular vesicles-Associated Fas ligand and TNF-Related apoptosis-inducing Ligand in pregnancies complicated by early and late Onset Preeclampsia. Front Physiol 12:708824. https://doi.org/10.3389/fphys.2021.708824
doi: 10.3389/fphys.2021.708824
pubmed: 34366896
pmcid: 8342945
Hasan S, Alshaikh B, Yusuf K (2021) Serum levels of soluble Fas and Fas ligand in pregnant women who smoke. Am J Reprod Immunol 85:e13382. https://doi.org/10.1111/aji.13382
doi: 10.1111/aji.13382
pubmed: 33247994
Tan S, Liu X, Chen L, Wu X, Tao L, Pan X, Tan S, Liu H, Jiang J, Wu B (2021) Fas/FasL mediates NF-kappaBp65/PUMA-modulated hepatocytes apoptosis via autophagy to drive liver fibrosis. Cell Death Dis 12:474. https://doi.org/10.1038/s41419-021-03749-x
doi: 10.1038/s41419-021-03749-x
pubmed: 33980818
pmcid: 8115181
Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, Gotsch F, Erez O (2022) The etiology of preeclampsia. Am J Obstet Gynecol 226:S844–S866. https://doi.org/10.1016/j.ajog.2021.11.1356
doi: 10.1016/j.ajog.2021.11.1356
pubmed: 35177222
pmcid: 8988238
Ma’ayeh M, Costantine MM (2020) Prevention of preeclampsia. Semin Fetal Neonatal Med 25:101123. https://doi.org/10.1016/j.siny.2020.101123
doi: 10.1016/j.siny.2020.101123
pubmed: 32513597
pmcid: 8236336
Hauspurg A, Jeyabalan A (2022) Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy. Am J Obstet Gynecol 226:S1211–S1221. https://doi.org/10.1016/j.ajog.2020.10.027
doi: 10.1016/j.ajog.2020.10.027
pubmed: 35177218
Jia X, Yang S, Wang X, Ruan J, Huang W (2023) HOXB3 promotes trophoblast cell proliferation, invasion, and migration to alleviate preeclampsia via mediating the Notch/Wnt/beta-catenin pathway. Eur J Pharmacol 960:176015. https://doi.org/10.1016/j.ejphar.2023.176015
doi: 10.1016/j.ejphar.2023.176015
pubmed: 37652291
Ma W, Zhao X, Xue N, Gao Y, Xu Q (2021) The LINC01410/miR-122-5p/NDRG3 axis is involved in the proliferation and migration of osteosarcoma cells. IUBMB Life 73:705–717. https://doi.org/10.1002/iub.2452
doi: 10.1002/iub.2452
pubmed: 33583123
Guo W, Gai Q, Ma Y, Shan Z, Wu J (2021) LINC01410 leads the migration, invasion and EMT of bladder cancer cells by modulating miR-4319 / Snail1. Cancer Cell Int 21:429. https://doi.org/10.1186/s12935-021-02119-z
doi: 10.1186/s12935-021-02119-z
pubmed: 34391433
pmcid: 8364693
Ma W, Gao Y, Zhang J, Yao X, Jia L, Xu Q (2021) Long noncoding RNA LINC01410 promotes tumorigenesis of osteosarcoma cells via miR-497-5p/HMGA2 axis. J Biochem Mol Toxicol 35:e22921. https://doi.org/10.1002/jbt.22921
doi: 10.1002/jbt.22921
pubmed: 34605103
Liu F, Wen C (2020) LINC01410 Knockdown suppresses cervical Cancer Growth and Invasion via Targeting miR-2467-3p/VOPP1 Axis. Cancer Manag Res 12:855–861. https://doi.org/10.2147/CMAR.S236832
doi: 10.2147/CMAR.S236832
pubmed: 32104067
pmcid: 7008191
Xu Q, He L, Ma L, Fan L, Yan L, Zhao X, Li Y (2020) LINC01410 accelerated the invasion and proliferation of osteosarcoma by sponging miR-3128. Aging 12:24957–24966. https://doi.org/10.18632/aging.103464
doi: 10.18632/aging.103464
pubmed: 33401246
pmcid: 7803582
Jiang T, Wang C, Zhu Y, Han H (2020) LINC01410 promotes cell proliferation and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis. J Gene Med 22:e3162. https://doi.org/10.1002/jgm.3162
doi: 10.1002/jgm.3162
pubmed: 31951299
Xu J, Wang L, Wang Q (2021) High expression of long noncoding RNA 01410 serves as a potential diagnostic and prognostic marker in patients with colorectal Cancer. Clin Lab 67. https://doi.org/10.7754/Clin.Lab.2020.200805
Musso T, Calosso L, Zucca M, Millesimo M, Ravarino D, Giovarelli M, Malavasi F, Ponzi AN, Paus R, Bulfone-Paus S (1999) Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood 93:3531–3539
doi: 10.1182/blood.V93.10.3531.410k32_3531_3539
pubmed: 10233906
Zhang Y, Yang H, Long Y, Zhang Y, Chen R, Shi J, Chen J (2021) circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion. Sci Rep 11:24357. https://doi.org/10.1038/s41598-021-03662-5
doi: 10.1038/s41598-021-03662-5
pubmed: 34934095
pmcid: 8692596
Gu Y, Chu X, Morgan JA, Lewis DF, Wang Y (2021) Upregulation of METTL3 expression and m6A RNA methylation in placental trophoblasts in preeclampsia. Placenta 103:43–49. https://doi.org/10.1016/j.placenta.2020.10.016
doi: 10.1016/j.placenta.2020.10.016
pubmed: 33070036
Guo Y, Song W, Yang Y (2022) Inhibition of ALKBH5-mediated m(6) a modification of PPARG mRNA alleviates H/R-induced oxidative stress and apoptosis in placenta trophoblast. Environ Toxicol 37:910–924. https://doi.org/10.1002/tox.23454
doi: 10.1002/tox.23454
pubmed: 34995009
Li XC, Jin F, Wang BY, Yin XJ, Hong W, Tian FJ (2019) The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA. Theranostics 9:3853–3865. https://doi.org/10.7150/thno.31868
doi: 10.7150/thno.31868
pubmed: 31281518
pmcid: 6587351
Zeng C, Huang W, Li Y, Weng H (2020) Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol 13:117. https://doi.org/10.1186/s13045-020-00951-w
doi: 10.1186/s13045-020-00951-w
pubmed: 32854717
pmcid: 7457244
Wan W, Ao X, Chen Q, Yu Y, Ao L, Xing W, Guo W, Wu X, Pu C, Hu X, Li Z, Yao M, Luo D, Xu X (2022) METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer 21:60. https://doi.org/10.1186/s12943-021-01447-y
doi: 10.1186/s12943-021-01447-y
pubmed: 35197058
pmcid: 8864846
Wang L, Yang Q, Zhou Q, Fang F, Lei K, Liu Z, Zheng G, Zhu L, Huo J, Li X, Peng S, Kuang M, Lin S, Huang M, Xu L (2023) METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma. Cancer Lett 559:216122. https://doi.org/10.1016/j.canlet.2023.216122
doi: 10.1016/j.canlet.2023.216122
pubmed: 36898427
Su X, Qu Y, Mu D (2023) The Regulatory Network of METTL3 in the nervous system: diagnostic biomarkers and therapeutic targets. Biomolecules 13. https://doi.org/10.3390/biom13040664
Zhang B, Jiang H, Dong Z, Sun A, Ge J (2021) The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases. Genes Dis 8:746–758. https://doi.org/10.1016/j.gendis.2020.07.011
doi: 10.1016/j.gendis.2020.07.011
pubmed: 34522705
Wang Y, Wang Y, Gu J, Su T, Gu X, Feng Y (2022) The role of RNA m6A methylation in lipid metabolism. Front Endocrinol (Lausanne) 13:866116. https://doi.org/10.3389/fendo.2022.866116
doi: 10.3389/fendo.2022.866116
pubmed: 36157445
Blaes J, Thome CM, Pfenning PN, Rubmann P, Sahm F, Wick A, Bunse T, Schmenger T, Sykora J, von Deimling A, Wiestler B, Merz C, Jugold M, Haberkorn U, Abdollahi A, Debus J, Gieffers C, Kunz C, Bendszus M, Kluge M, Platten M, Fricke H, Wick W, Lemke D (2018) Inhibition of CD95/CD95L (FAS/FASLG) signaling with APG101 prevents Invasion and enhances Radiation Therapy for Glioblastoma. Mol Cancer Res 16:767–776. https://doi.org/10.1158/1541-7786.MCR-17-0563
doi: 10.1158/1541-7786.MCR-17-0563
pubmed: 29453321
Magerus A, Bercher-Brayer C, Rieux-Laucat F (2021) The genetic landscape of the FAS pathway deficiencies. Biomed J 44:388–399. https://doi.org/10.1016/j.bj.2021.06.005
doi: 10.1016/j.bj.2021.06.005
pubmed: 34171534
pmcid: 8514852
Guegan JP, Ginestier C, Charafe-Jauffret E, Ducret T, Quignard JF, Vacher P, Legembre P (2020) CD95/Fas and metastatic disease: what does not kill you makes you stronger. Semin Cancer Biol 60:121–131. https://doi.org/10.1016/j.semcancer.2019.06.004
doi: 10.1016/j.semcancer.2019.06.004
pubmed: 31176682
Lan R, Yang Y, Song J, Wang L, Gong H (2021) Fas regulates the apoptosis and migration of trophoblast cells by targeting NF-kappaB. Exp Ther Med 22:1055. https://doi.org/10.3892/etm.2021.10489
doi: 10.3892/etm.2021.10489
pubmed: 34434269
pmcid: 8353647
Khan D, Cornelius JF, Muhammad S (2023) The role of NF-kappaB in intracranial aneurysm pathogenesis: a systematic review. Int J Mol Sci 24. https://doi.org/10.3390/ijms241814218
Rastogi S, Aldosary S, Saeedan AS, Ansari MN, Singh M, Kaithwas G (2023) NF-kappaB mediated regulation of tumor cell proliferation in hypoxic microenvironment. Front Pharmacol 14:1108915. https://doi.org/10.3389/fphar.2023.1108915
doi: 10.3389/fphar.2023.1108915
pubmed: 36891273
pmcid: 9986608
Zheng L, Shi L, Zhou Z, Chen X, Wang L, Lu Z, Tang R (2018) Placental expression of AChE, alpha7nAChR and NF-kappaB in patients with preeclampsia. Ginekol Pol 89:249–255. https://doi.org/10.5603/GP.a2018.0043
doi: 10.5603/GP.a2018.0043
pubmed: 30084476